Small Molecules, Biologics, Viral
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
90
NCT07068191
Gepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly
Phase: N/A
Role: Lead Sponsor
Start: Jun 19, 2025
Completion: Aug 31, 2025
Loading map...